Jeffrey P. Murry

Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing

Datsen G. Wei, Vicki Chiang, Elizabeth Fyne et al. · PLoS Pathogens · 2014 · 281 citations · Full text

Medicine, Immunology, Pharmacology +17

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes

R. Brad Jones, Stefanie Mueller, Rachel W O’Connor et al. · PLoS Pathogens · 2016 · 165 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy

Angela Tsai, Alivelu Irrinki, Jasmine Kaur et al. · Journal of Virology · 2017 · 161 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency

Lars Pache, Míriam Santos Dutra, Adam M. Spivak et al. · Cell Host & Microbe · 2015 · 149 citations · Full text

Life Sciences, Microbiology, Molecular Biology +11

Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells

Derek D. Sloan, Chia‐Ying K. Lam, Alivelu Irrinki et al. · PLoS Pathogens · 2015 · 96 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17